End users who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for:
Manufacturing / MSAT
Technical Operations and Quality
Quality Over Quantity
Supply Chain and Manufacturing
Investigational Material Supply Chain
AI - New Technologies
Cell Line Development
Cell Gene Manufacturing
End Users 60%
Buying power 90%
Evolving and digitising toward next-generation bioprocessing
15th Annual BILS 2023 is an in-person boutique summit for up to 200 decision makers looking to gain critical insight into key challenges across bioprocessing.
Keynote Topics Include:
Implementing long-term investments into emerging technologies and strategies to keep competitive in future next-generation facilities.
Increased Focus On Human Resources - Attract - Train - Retain
New approaches to reduce and transform batch losses.
Pragmatic solutions to avoid equipment failures
Other Programme Topics Include
Lowering timelines from concepts to clinical approvals and beyond
Key Applications of artificial intelligence and digitalisation
Identifying bioprocessing innovations for next-generation antibody-based modalities
Creating an effective adoption of single-use systems and continuous bioprocessing